Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

(13:27)

2018 RNDS — MOG Antibody-Associated Disease

(23:37)

NMO MOG Treatment Approach

(3:24)

912. MOG Antibody Disease: Diagnosis and Treatment Guidelines

(55:39)

2022 Pre-RNDS | MOG Antibody Disease (MOGAD)

(22:1econd)

What is MOG Antibody Disease? (MOGAD)

(9:7)

605. What is MOG antibody-associated disease?

(1:26)

808. MOG Antibody Disease: Adult and Pediatric Presentations

(54:7)

2021 RNDS | MOG Antibody Disease (MOGAD)

(28:)

MOG antibody seropositivity in a multi-ethnic population

(3:21)

Myelin Oligodendrocyte Glycoprotein (MOG)

(4:11)

2019 RNDS — Session on the Diagnosis and Treatment of MOG Antibody-Associated Disease

(24:)

Controversies in treating NMOSD and MOGAD

(1:54)

MOG Antibody Disease Treatments Explained | Understanding Types of Treatment

(9:27)

MOG Antibody Disease (MOGAD) Symptoms \u0026 Presentations

(4:37)

Predictors of conversion from positive to negative MOG antibody status

(1:44)

Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?

(35:29)

Features of MOG required for recognition by patients with MOG antibody-associated disorders

(5:37)

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and NMOSDs

(1:51)